Welcome to LookChem.com Sign In|Join Free

CAS

  • or

342371-84-0

Post Buying Request

342371-84-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

342371-84-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 342371-84-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,2,3,7 and 1 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 342371-84:
(8*3)+(7*4)+(6*2)+(5*3)+(4*7)+(3*1)+(2*8)+(1*4)=130
130 % 10 = 0
So 342371-84-0 is a valid CAS Registry Number.

342371-84-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 9-deoxo-6-deoxy-6,9-epoxy-9,9a-didehydro-9a-aza-homoerythromycin A

1.2 Other means of identification

Product number -
Other names erythromycin A 6,9-imino ether

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:342371-84-0 SDS

342371-84-0Relevant articles and documents

Synthesis and antibacterial activity of new 4″-O-carbamates of 11,12-cyclic carbonate erythromycin A 6,9-imino ether

Zhang, Ling,Jiao, Bo,Yang, Xiangrui,Liu, Lin,Ma, Shutao

, p. 243 - 247 (2011)

A series of new 4″-O-carbamates of 11,12-cyclic carbonate erythromycin A 6,9-imino ether were synthesized and evaluated for their in vitro antibacterial activity. All the desired compounds demonstrated favorable activity (0.03 μg ml-1) against erythromycin-susceptible Streptococcus pneumoniae comparable to the references, exhibiting 133-fold higher activity than precursor 2 or 3. Similarly, all of the analogs exhibited improved activity against the erythromycin-resistant S. pneumoniae encoded by the erm gene and the erm and mef genes, showing 4-32-fold more effectiveness than erythromycin A.

Synthesis method of azithromycin

-

Paragraph 0003; 0025-0026, (2017/08/29)

The invention relates to a synthesis method of azithromycin. The synthesis method is characterized by comprising the process steps of firstly adding sodium bicarbonate and a rearrangement reaction reagent to erythromycin oxime in a reaction system employing water as a reaction solvent for rearrangement reaction, carrying out heat preservation for 2-3 hours, dropwise adding a reduction reaction regent for reduction reaction and stirring for 1-2 hours during heat preservation; adding a competitive inhibitor for removing boron through reduction hydrolysis for reduction and boron removal reaction; and finally separating out crystal, and cooling and filtering to obtain the azithromycin. Rearrangement and reduction are simultaneously carried out in the same reaction system. Compared with a sodium borohydride reduction method in the prior art, the synthesis method has the advantages that the process is simplified, use of an organic solvent and the like is omitted, the environmental pollution and the product cost are reduced, the influence of a complicated process on the quality of a product is reduced, the quality and the yield of the product are finally improved and the synthesis method is suitable for technological production.

Preparation method of erythromycin 6,9-imino ether compound

-

Paragraph 0021, (2017/04/25)

The invention relates to a preparation method of an erythromycin 6,9-imino ether compound. According to the method, a reaction of acid-catalyzed erythromycin thiocyanate and N-hydroxyamide is adopted, an oximation reaction of erythromycin and a rearrangement reaction of erythromycin oxime are conducted in a one-step mode, and erythromycin 6,9-imino ether is generated. The preparation method of the compound comprises the preparation steps that erythromycin thiocyanate, N-hydroxyamide and acid are taken and added into an organic solvent, heating is conducted, extracting, drying by distillation and water adding are conducted after the reaction is completed, the pH value of the solution is adjusted to range from 10 to 12, precipitating, filtering and drying are conducted, and the erythromycin 6,9-imino ether product is obtained. According to the preparation method, the erythromycin 6,9-imino ether compound is synthesized in a one-step mode, operation is easy, the method is economical and efficient, a venomous sulfonyl chloride reagent is not used, environmental pollution is less, the yield is high, and the application prospect is wide.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 342371-84-0